The PE Ratio as of June 2026 (TTM) for Pacific Biosciences of California, Inc. (PACB) is -3.20

According to Pacific Biosciences of California, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.20. This represents a change of -37.39% compared to the average of -5.11 of the last 4 quarters.

Pacific Biosciences of California, Inc. (PACB) Historical PE Ratio (quarterly & annually)

How has PACB PE Ratio performed in the past?

The mean historical PE Ratio of Pacific Biosciences of California, Inc. over the last ten years is 7.95. The current -3.20 PE Ratio has changed -4125.05% with respect to the historical average. Over the past ten years (40 quarters), PACB's PE Ratio was at its highest in in the March 2020 quarter at 93.02. The PE Ratio was at its lowest in in the December 2019 quarter at -2161.21.

Pacific Biosciences of California, Inc. (PACB) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Pacific Biosciences of California, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pacific Biosciences of California, Inc. (PACB) Average PE Ratio

How has PACB PE Ratio performed in the past?

The current PE Ratio of Pacific Biosciences of California, Inc. (PACB) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Pacific Biosciences of California, Inc. (PACB) PE Ratio vs. Peers

How is PACB’s PE Ratio compared to its peers?

Pacific Biosciences of California, Inc.’s PE Ratio is greater than Avanos Medical, Inc. (-16.69), greater than Orthofix Medical Inc. (-6.28), greater than SI-BONE, Inc. (-40.59), greater than Butterfly Network, Inc. (-18.75), less than DarioHealth Corp. (5.59), greater than Iovance Biotherapeutics, Inc. (-4.83), less than Integra LifeSciences Holdings Corporation (-2.76), greater than Fulgent Genetics, Inc. (-7.82), less than Ginkgo Bioworks Holdings, Inc. (-1.54), less than POMDOCTOR Ltd (-0.57),

Build a custom stock screener for Pacific Biosciences of California, Inc. (PACB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pacific Biosciences of California, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pacific Biosciences of California, Inc. (PACB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pacific Biosciences of California, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.